Amundi Dr Reddys Laboratories LTD Transaction History

Amundi

$239 Billion
Q1 2024

A detailed history of Amundi transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Amundi holds 15,935 shares of RDY stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,935

Previous 97,142 83.6%

Holding current value

$1.21 Million

Previous $6.76 Million 82.72%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$67.36 - $77.59 $5.47 Million - $6.3 Million	-81,207 Reduced 83.6%	15,935 $1.17 Million
Q4 2023 Feb 14, 2024	BUY	$64.27 - $69.9 $3.77 Million - $4.1 Million	58,678 Added 152.55%	97,142 $6.76 Million
Q3 2023 Nov 14, 2023	BUY	$61.9 - $72.77 $588,050 - $691,315	9,500 Added 32.8%	38,464 $2.57 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $112,014 - $132,531	2,100 Added 7.82%	28,964 $1.83 Million
Q1 2023 May 15, 2023	SELL	$51.63 - $56.93 $474,996 - $523,756	-9,200 Reduced 25.51%	26,864 $1.53 Million

Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $629,145 - $706,635	12,300 Added 51.76%	36,064 $1.87 Million
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $1.88 Million - $2.16 Million	-37,700 Reduced 61.34%	23,764 $1.28 Million
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $635,136 - $744,064	12,800 Added 26.3%	61,464 $3.52 Million
Q1 2022 May 16, 2022	SELL	$48.27 - $65.25 $853,944 - $1.15 Million	-17,691 Reduced 26.66%	48,664 $2.76 Million
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $1.09 Million - $1.23 Million	-18,300 Reduced 21.62%	66,355 $4.21 Million
Q3 2021 Nov 15, 2021	BUY	$60.19 - $75.29 $1.11 Million - $1.39 Million	18,400 Added 27.77%	84,655 $5.51 Million
Q2 2021 Aug 16, 2021	BUY	$62.12 - $74.2 $4.12 Million - $4.92 Million	66,255 New	66,255 $4.87 Million

Others Institutions Holding RDY

# of Institutions

242

Shares Held

23.6M

Call Options Held

25.2K

Put Options Held

8.5K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account